UK markets closed

Zomedica Pharmaceuticals Corp. (ZOM)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.1330+0.0029 (+2.23%)
At close: 04:00PM EDT
0.1338 +0.00 (+0.60%)
After hours: 07:56PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-17,496
-34,529
-17,015
-18,384
-16,912
Depreciation & amortisation
3,639
6,298
4,042
1,139
530.02
Deferred income taxes
-1,489
-1,489
-2,540
-
-
Stock-based compensation
9,041
6,263
7,891
7,092
1,656
Change in working capital
-8,979
19
-3,163
-3,876
-1,716
Accounts receivable
-482.076
-617
-283
-47
0
Inventory
-4,536
-1,059
-4,008
-2,774
0
Accounts payable
1,216
384
3,454
1,412
-838.897
Other working capital
-15,098
-20,621
-12,696
-14,802
-16,256
Other non-cash items
10.738
-1,987
16
38
22.069
Net cash provided by operating activities
-14,189
-15,975
-11,670
-14,276
-16,239
Cash flows from investing activities
Investments in property, plant and equipment
-909.174
-4,646
-1,026
-526
-16.794
Acquisitions, net
-23,959
-23,959
-24,304
-71,399
0
Purchases of investments
-12,593
-12,593
-130,550
0
-
Sales/maturities of investments
42,775
42,775
-
-
-
Other investing activities
-
-
-
-
1,002
Net cash used for investing activities
-212,111
1,577
-155,880
-71,925
1,006
Cash flows from financing activities
Common stock issued
0
-
0
199,525
56,496
Other financing activities
-
-
-
-14,270
986.96
Net cash used provided by (used for) financing activities
31.366
0
8
219,159
76,715
Net change in cash
-226,269
-14,398
-167,542
132,958
61,481
Cash at beginning of period
271,412
27,399
194,952
61,992
510.586
Cash at end of period
45,143
12,952
27,399
194,952
61,992
Free cash flow
Operating cash flow
-14,189
-15,975
-11,670
-14,276
-16,239
Capital expenditure
-909.174
-4,646
-1,026
-526
-16.794
Free cash flow
-15,098
-20,621
-12,696
-14,802
-16,256